Andrew Blauvelt, MD, MBA

Blauvelt Conosulting, LLC

Dr. Blauvelt is a Consultant and Owner of Blauvelt Consulting, LLC. He received his BS at Purdue University, his MD at Michigan State University, and a healthcare MBA at Oregon Health & Science University (OHSU). Dr. Blauvelt trained in dermatology at the University of Miami and in cellular immunology at the National Institutes of Health (NIH). Earlier in his career, he held senior staff positions at the NIH, OHSU, and the Portland VA Medical Center as well as being Owner and President of Oregon Medical Research Center for 10 years. Dr. Blauvelt has published over 450 papers and spoken across the country and world on immunology, psoriasis, and atopic dermatitis. Within psoriasis research, his laboratory published key papers on the role of IL-23/Th17 biology in this disease. In recent years, he has been the international lead/senior investigator on numerous important clinical trials in psoriasis, atopic dermatitis, and other diseases, including KNOCKOUT. Dr. Blauvelt is also an elected member of the International Psoriasis Council and the International Eczema Council; he became Chair of the Medical Board for the National Psoriasis Foundation in 2023, an organization he has worked closely with for over 25 years in a variety of capacities.